glp-1-based weight-loss drugs GLP-1 weight loss drug study finds small increase in risk of osteoporosis and gout GLP-1 Medications for Weight Loss:

Digestive Enzyme Supplementation in Gastrointestinal Diseases

Topical vs Injectable Tolerability Topical GHK-Cu appears better tolerated than injectable forms, with topical side effects typically limited to mild redness, itching, or irritation at application site and rare copper uglies phenomenon (anecdotal accelerated skin aging appearance due to potential MMP upregulation, not well-studied)

[5] Stephens FB, et al, 2006a: An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle

[3] Research has demonstrated that individuals with fatty liver disease frequently exhibit reduced hepatic glutathione levels

This means continuous growth hormone pulses instead of single spikes